A new study, with contributions made from two CDF Medical Advisory Board Members, Martin Kagnoff and Joseph A. Murray, has identified antibody biomarkers that can be potentially used to diagnose nonresponsive celiac disease.
Continue ReadingCeliac disease, one of the most common autoimmune diseases in the world today, often goes undiagnosed due to asymptomatic patients and many nonspecific symptoms. To diagnose a patient with celiac…
Continue ReadingAlternatives to gluten are absolutely vital to those diagnosed with celiac disease as the only treatment available currently is a life-long, strict gluten-free diet. Many doctors and nutritionists recommend foods…
Continue ReadingA recent study published by the American Journal of Epidemiology by several scientists including Dr. Peter H. R. Green, the founder of the Columbia University Celiac Disease Center and a…
Continue ReadingCeliac disease (CD) is an autoimmune disease associated with small intestinal damage and villous atrophy. It occurs in genetically susceptible people of all ages and can involve a variety of…
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...